Rishabh Sharma

Rishabh Sharma

Auto-generated profile, based on publicly available information

Rishabh Sharma

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
RSRishabh Sharma
Rishabh Sharma
SSSandy R. Shultz
Sandy R. Shultz
MRMarcus J. Robinson
Marcus J. Robinson
ABAntonio Belli
Antonio Belli
MHMargaret L. Hibbs
Margaret L. Hibbs
BSBridgette Semple
Bridgette Semple

9 November 2019 in Brain Sciences
Verified
Journal Article
Open access
PDF file
RSRishabh Sharma
Rishabh Sharma
WLWai Lam Leung
Wai Lam Leung
AZAkram Zamani
Akram Zamani
TOTerence J. O’brien
Terence J. O’brien
PCPablo Miguel Casillas-Espinosa
Pablo Miguel Casillas-Espinosa
BSBridgette Semple
Bridgette Semple
Epilepsy is a common chronic consequence of traumatic brain injury (TBI), contributing to increased morbidity and mortality for survivors. As post-traumatic epilepsy (PTE) is drug-resistant in at least one-third of patients, there is a clear need for novel therapeutic strategies to prevent epilepsy from developing after TBI, or to mitigate its severity. It has long been recognized that seizure activity is associated with a local immune response, characterized by the activation of microglia and astrocytes and the release of a plethora of pro-inflammatory cytokines and chemokines. More recently, increasing evidence also supports a causal role for neuroinflammation in seizure induction and propagation, acting both directly and indirectly on neurons to promote regional hyperexcitability. In this narrative review, we focus on key aspects of the neuroinflammatory response that have been implicated in epilepsy, with a particular focus on PTE. The contributions of glial cells, blood-derived leukocytes, and the blood–brain barrier will be explored, as well as pro- and anti-inflammatory mediators. While the neuroinflammatory response to TBI appears to be largely pro-epileptogenic, further research is needed to clearly demonstrate causal relationships. This research has the potential to unveil new drug targets for PTE, and identify immune-based biomarkers for improved epilepsy prediction.